Alkermes Inc Drug Patent Portfolio

Alkermes Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Alkermes Inc News

Alkermes Hit with Antitrust Lawsuit for Allegedly Trying to Prevent Generic Vivitrol from Entering the Market

06 Oct, 2025

Alkermes witnesses a 10% rise in share price due to positive updates on Lybalvi - Fierce Pharma

15 Feb, 2024

See More